Patent · US Active

Treatment of allergic rhinitis using a combination of mometasone and olopatadine

US11400101B2 · kind B2 · utility

0Cited by

8References

26Claims

0Family size

Assignee

GLENMARK SPECIALTY S.A. · CH

Inventors

Neelima Khairatkar-Joshi · Thane, IN
Abhay Kulkarni · Navi Mumbai, IN
Dinesh Pradeep Wale · Osmanabad, IN
Vikram M. Bhosale · Mumbai, IN
Piyush Agarwal · Mumbai, IN
Patrick Keohane · London, GB
Sudeesh K. Tantry · Jamison, US
Chad Oh · San Francisco, US

Key dates

Filing date	Aug 26, 2020
Grant date	Aug 2, 2022
Priority date	—
Expiry date	Aug 26, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M15/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.